---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-011275"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T03:31:16.528094+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sanuwave Health receives Nasdaq approval; trading expected to start March 7 under SNWV

## Summary
- Common stock approved for listing on Nasdaq Global Market; trading begins March 7, 2025.
- Ticker 'SNWV' unchanged from OTCQB; no stockholder action required.
- Board approved amended bylaws including exclusive forum, proxy rules, and director cap increase to 10.
- New Code of Business Conduct and Ethics adopted effective March 4, 2025.
- CEO Morgan Frank cites 'transition and progress' and expects uplisting to drive shareholder value.

## SEC filing metadata
- accession: 0001628280-25-011275
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 5.05, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/snwv-20250303.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-011275
- JSON: https://secwatch.observer/filing/0001628280-25-011275.json
- Plain text: https://secwatch.observer/filing/0001628280-25-011275.txt

## Key facts
- Governance Changes
  SANUWAVE Health, Inc.: Approve Amended and Restated Bylaws changing notice windows, special meeting prohibition, proxy color, board size, forum selection, and other administrative updates (effective 2025-03-04).
  - Change: bylaw amendment
  - Effective: 2025-03-04
  source text: In connection with the Uplisting (as defined below), on March 4, 2025, the Board of Directors (the “Board”) of Sanuwave Health, Inc. (the “Company”) approved Amended and Restated Bylaws of the Company (the “A&R Bylaws”), which amend and restate the Company’s existing bylaws (the “Existing Bylaws”) in their entirety.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm
- Governance Changes
  SANUWAVE Health, Inc.: Approved a new Code of Business Conduct and Ethics (effective 2025-03-04).
  - Change: code of ethics
  - Effective: 2025-03-04
  source text: In connection with the Uplisting, on March 4, 2025, the Board approved a new Code of Business Conduct and Ethics.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000162828025011275/0001628280-25-011275-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.